SCHEMBL30087109

SCHEMBL30087109

CC(C)(C)[Si](C)(C)OCC#Cc1cc(C#N)cnc1CO

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.30
▸ EGLN1 Q9GZT9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27176907 1.00 HPGDS (0.30) HPGDSEGLN1
SCHEMBL30087127 0.83 — —
SCHEMBL27176911 0.83 — —
SCHEMBL27176822 0.78 HTR7 (0.32) HPGDS
SCHEMBL23051557 0.70 GAA (0.42) —
SCHEMBL29707038 0.70 GAA (0.42) —
SCHEMBL23043878 0.69 KDM4E (0.34) —
SCHEMBL9091041 0.68 — —
SCHEMBL2160545 0.67 — —
SCHEMBL29395259 0.65 KDM4E (0.39) HPGDSEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341255-A1 MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS Eli Lilly and Company (US) 2024-03-27 — — EP disclosed
WO-2022246019-A1 MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2022-11-24 — — WO disclosed
Send feedback